Low-dose aspirin and survival from lung cancer: a population-based cohort study

BACKGROUND: Preclinical evidence suggests that aspirin may inhibit lung cancer progression. In a large cohort of lung cancer patients, we investigated whether low-dose aspirin use was associated with a reduction in the risk of lung cancer-specific mortality. METHODS: We identified lung cancer patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Mc Menamin, Úna C., Cardwell, Chris R., Hughes, Carmel M., Murray, Liam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647502/
https://www.ncbi.nlm.nih.gov/pubmed/26573580
http://dx.doi.org/10.1186/s12885-015-1910-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647502/
https://www.ncbi.nlm.nih.gov/pubmed/26573580
http://dx.doi.org/10.1186/s12885-015-1910-9

Ejemplares similares